Literature DB >> 28432434

Ventricular androgenic-anabolic steroid-related remodeling: an immunohistochemical study.

Rossana Cecchi1, Barbara Muciaccia2, Costantino Ciallella2, Natale Mario Di Luca2, Akihiko Kimura3, Cristina Sestili4, Mizuho Nosaka2, Toshikazu Kondo5.   

Abstract

BACKGROUND: Several fatal cases of bodybuilders, following a myocardial infarction after long exposure to androgenic-anabolic steroids (AAS), are reported. In recent years, evidence has emerged of cases of heart failure related to AAS consumption, with no signs of coronary or aorta atherosclerosis. This study aims to further investigate the pathogenesis of the ventricular AAS-related remodeling performing immunohistochemistry (IHC).
METHOD: In order to examine innate immunity activity and myocytes and endothelial cell apoptosis, IHC analyses were performed on heart tissue of two cases of bodybuilders who died after years of supratherapeutic use of metelonone and nandrolone and where no atherosclerosis or thrombosis were found, using the following antibodies: anti-CD68, anti-iNOS, anti-CD163, anti-CD 15, anti-CD8, anti-CD4, anti-HIF1 α, and in situ TUNEL staining.
RESULTS: Results confirm the experimental findings of recent research that, in the absence of other pathological factors, if intensive training is combined with AAS abuse, myocytes and endothelial cells undergo apoptotic alterations. The absence of inflammatory reactions and the presence of an increased number of M2 macrophages in the areas of fibrotic remodeling confirm that the fibrotic changes in the heart are apoptosis-related and not necrosis-related.
CONCLUSIONS: In conclusion, the study indicates that, in very young subjects with chronic hypoxia-related alterations of the heart, signs of a heart failure in the other organs and a history of AAS abuse, death can be ascribed to progressive heart failure due to the direct apoptotic cardiac and endothelial changes produced by AAS.

Entities:  

Keywords:  Androgenic-anabolic steroids; Apoptosis; Autopsy; Chronic hypoxic changes; Death; Heart failure; Myocardial remodeling

Mesh:

Substances:

Year:  2017        PMID: 28432434     DOI: 10.1007/s00414-017-1589-3

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  34 in total

1.  Different signaling pathways induce apoptosis in endothelial cells and cardiac myocytes during ischemia/reperfusion injury.

Authors:  Tiziano M Scarabelli; Anastasis Stephanou; Evasio Pasini; Laura Comini; Riccardo Raddino; Richard A Knight; David S Latchman
Journal:  Circ Res       Date:  2002-04-05       Impact factor: 17.367

2.  Sudden unexpected death in a female fitness athlete, with a possible connection to the use of anabolic androgenic steroids (AAS) and ephedrine.

Authors:  I Thiblin; H Mobini-Far; M Frisk
Journal:  Forensic Sci Int       Date:  2008-12-24       Impact factor: 2.395

Review 3.  Genetics of athletic performance.

Authors:  Elaine A Ostrander; Heather J Huson; Gary K Ostrander
Journal:  Annu Rev Genomics Hum Genet       Date:  2009       Impact factor: 8.929

Review 4.  Performance enhancing drugs (doping agents) and sudden death--a case report and review of the literature.

Authors:  R Hausmann; S Hammer; P Betz
Journal:  Int J Legal Med       Date:  1998       Impact factor: 2.686

Review 5.  Caspases: the proteases of the apoptotic pathway.

Authors:  G Nuñez; M A Benedict; Y Hu; N Inohara
Journal:  Oncogene       Date:  1998-12-24       Impact factor: 9.867

6.  Cardiac hypertrophy in deceased users of anabolic androgenic steroids: an investigation of autopsy findings.

Authors:  Hamid Reza Mobini Far; Greta Ågren; Ingemar Thiblin
Journal:  Cardiovasc Pathol       Date:  2011-11-21       Impact factor: 2.185

7.  Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction.

Authors:  Aaron L Baggish; Rory B Weiner; Gen Kanayama; James I Hudson; Michael H Picard; Adolph M Hutter; Harrison G Pope
Journal:  Circ Heart Fail       Date:  2010-04-27       Impact factor: 8.790

8.  M1 and M2 macrophages: the chicken and the egg of immunity.

Authors:  Charles D Mills; Klaus Ley
Journal:  J Innate Immun       Date:  2014-08-13       Impact factor: 7.349

9.  Anabolic steroid abuse and cardiac sudden death: a pathologic study.

Authors:  V Fineschi; G Baroldi; F Monciotti; L Paglicci Reattelli; E Turillazzi
Journal:  Arch Pathol Lab Med       Date:  2001-02       Impact factor: 5.534

10.  Medico-legal aspects of doping.

Authors:  B Madea; W Grellner; F Musshoff; R Dettmeyer
Journal:  J Clin Forensic Med       Date:  1998-03
View more
  4 in total

Review 1.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

Review 2.  Public health impact of androgens.

Authors:  Gen Kanayama; Marc J Kaufman; Harrison G Pope
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2018-06       Impact factor: 3.243

3.  A unique case of tachycardia-mediated cardiomyopathy in a patient misusing anabolic steroids.

Authors:  Govinda Adhikari; Ashiya Khan; Nasheed Shams; Mustafa H Hassan; Arvind Kunadi
Journal:  Clin Case Rep       Date:  2022-06-13

Review 4.  Anabolic-androgenic steroids and cardiovascular risk.

Authors:  Jian-Di Liu; Yan-Qing Wu
Journal:  Chin Med J (Engl)       Date:  2019-09-20       Impact factor: 2.628

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.